Hyperpigmentation Treatment Market: Global Industry Analysis and Forecast (2024-2030)
Hyperpigmentation Treatment market Size was valued at USD 2.70 Billion in 2023. The market is expected to grow at a CAGR of 8.64% during the forecast period of 2024-2030. Reaching nearly USD 6.08 Billion by 2030
Format : PDF | Report ID : SMR_2468
Hyperpigmentation Treatment Market Overview
Pigmentation is the part of the skin that is darker in color than the surrounding skin, frequently giving the area a patchy or uneven look. Freckles and sunspots, melasma or chloasma, seborrheic keratosis, and birthmarks were examples of the pigmentation and it can be made worse by using ineffective skin care products, continued sun exposure, and heat injury.
The hyperpigmentation treatment market is expected to grow during the forecasting period driven by increasing skincare awareness, the high impact of social media on skincare and beauty standards, and technological advancement products that improve the efficacy of hyperpigmentation treatments.
The North American region is expanding driven by the advanced healthcare infrastructure and widespread access to dermatological services. The presence of leading pharmaceutical and skincare companies, coupled with robust research and development activities, promote innovation and drives the introduction of new hyperpigmentation treatment options. Asia- Pacific and Europe regions are also experiencing growth due to increasing disposable incomes, greater awareness of skin health, and the availability of advanced treatments
The key players in the Hyperpigmentation Treatment Market are Vivier Pharma, L’Oreal Paris, La Roche-Posay, and Pierre Fabre Dermo Cosmetique, Bayer, Alvogen, Allergen, SkinCeuticals International, and others. La Roche-posay is a top treatment offers skincare products designed to treat on skin related issues. The brand is highly recommended by dermatologists for is gentle formulas and focus on condition like eczema, dryness and acne. Hospitals and dermatology clinics dominate the hyperpigmentation treatment market by offering a range of professional and advanced treatment options. The expertise and comprehensive care provided in these facilities make them the preferred choice for individuals seeking reliable and significant improvements in their skin condition. The hyperpigmentation market is poised for robust growth, supported by technological innovations, rising awareness, and expanding treatment options.
To get more Insights: Request Free Sample Report
Hyperpigmentation Treatment Market Dynamics
Drivers
High impact of social media on beauty standards, and technological advancement in the hyperpigmentation treatment products.
The high impact of social media on beauty standards has led to people opting for skin tone and spotless skin, which has raised demand for hyperpigmentation treatment products. As a consequence, the demand for hyperpigmentation treatments has surged, driven by the desire to attain the flawless complexion promoted on social media platforms. Users, influenced by the digitally altered and filtered images, seek remedies to address pigmentation concerns and achieve the idealized beauty portrayed online. Thus, the impact of social media on beauty standards is expected to drive the growth of the hyperpigmentation treatment market. Technological advancements like nanotechnology bring hyperpigmentation active ingredients such as hydroquinone, arbutin, kojic acid, azelaic acid, and retinoic acid to improve product efficacy in treating hyperpigmentation, which is expected to drive the growth of the hyperpigmentation market share. The nanoparticles allow for the delivery of the active ingredients to the melanin- producing cells, such as melanocytes, to target the pigmentation problem. Because of their high surface area-to-volume ratio, therapeutic agents can be encapsulated and protected by nanoparticles, which increases stability and prevents degradation.
Rising Disposable Income and Spending on Cosmetic Procedures
Consumer are largely spending on cosmetic procedures due to the economic growth and a growing focus on personal appearance and well-being. As individuals experience a boost in their earnings and financial stability, they are more likely to invest in services and products that improve their quality of life and satisfaction. Cosmetic procedures, ranging from Botox and fillers to more extensive cosmetic surgeries, are available and the advancement in technology have made these procedures more affordable and effective to people. As individuals focuses on their self-care and grooming, the demand for cosmetics services continues to grow. This trend is supported by an expanding market of cosmetic providers and innovative treatments, which cater to diverse consumer needs and preferences. As a result, the cosmetic industry is booming, with more investment from both consumers and businesses.
Opportunities
Rise in awareness about skincare provide significant market growth opportunities
The hyperpigmentation treatment market has experienced significant growth due to a rise in awareness about skincare and increased access to information. Recently, there has been a clear change in consumer behaviour, with an increasing emphasis on skincare as an essential aspect of overall well-being. The awareness of skincare and makeup products has changed as consumers are increasingly exploring innovative solutions, such as topical creams, serums, chemical peels, and laser therapies, that promise to remove dark spots, even skin tone, and restore radiance. Also, the educational content from reputable sources, including dermatologists and skincare experts, has made it easier for individuals to understand the causes and treatments of hyperpigmentation. Websites, blogs, and online forums provide valuable advice on managing skin conditions, promoting a more informed consumer base that actively seeks effective treatments. The expanding range of skincare brands and clinics offering specialized treatments has contributed to the growth of the hyperpigmentation treatment market. Skincare companies and treatment providers have invested in this trend by developing and marketing innovative solutions targeting hyperpigmentation. Hence, the rise in awareness about skin care is expected to provide a significant market growth opportunity for hyperpigmentation treatment.
Challenges
High costs of hyperpigmentation treatments limit market growth
Cost is key factor in hyperpigmentation treatment market, as it depends on the technique used, the time and effort evolved, and the professional expertise of the surgeon performing the treatment. The expense associated with cosmetic procedures make them exclusive, which limiting the market expansion. As a result, only those with higher disposable incomes or significant financial resources are able to afford these treatments. This limits the overall growth potential of the market and may prevent the broader adoption of cosmetic procedures. The high-cost impact consumer confidence and willingness to spend on these services. Potential customers might hesitant to spend money on procedures, particularly if they are unsure of the results. This hesitation limits the market's growth and the widespread acceptance of cosmetic procedures.
Hyperpigmentation Treatment Market Segment Analysis
By Treatment
The Phototherapy segment is expected to grow during the forecast period of 2024-2030, due to the high effectiveness of phototherapy devices such as medical lasers in treating hyperpigmentation. Phototherapy allows for highly targeted treatment of hyperpigmented areas as it is highly suitable for a wide range of skin types and tones. The availability of skilled professionals and continuous innovation in energy-based devices also contribute to the segment's dominance in the overall market. Light-based technologies can be precisely targeted at hyperpigmented skin areas, providing targeted therapeutic effects. This inclusiveness is crucial in addressing the diverse demographic makeup of individuals seeking hyperpigmentation treatment. The topical agents segment dominated the global hyperpigmentation treatment market in 2023, due to its lower cost and easy availability. The common topical drugs recommended are hydroquinone, azelaic acid, and L-ascorbic acid. Topical treatment involves use of creams, lotion, ointments and serum topically to treat various pigmentation problems.
By End User
By end user, the dermatological clinic segment is expected to hold the highest share in the forecasting period of 2024-2030, due to the increasing number of skin problems and the rising prevalence of pigmentation disorders. Dermatology clinics offer a wide range of advanced treatment options, like laser treatments, chemical peels and bleaches, and microneedling. The availability of personalized treatment plans and comprehensive follow-up care in clinics improved patient outcomes and satisfaction. The growing awareness of skin rejuvenation and rising demand for cosmetic dermatology services have expected dermatology clinics to dominate the market. Aesthetics centre segment is expected to grow fast during the forecast period of 2024-2030, driving by the rise in adoption of the home care laser and microdermabrasion devices for hyperpigmentation treatment.
Hyperpigmentation Treatment Market Regional Insights
North America dominated the hyperpigmentation treatment market in 2023, due to the high incidence of pigmentation disorders, increasing numbers of clinics and hospitals, advanced healthcare infrastructure, and major market players offering effective pigmentation treatments. The availability of advanced treatment options and the presence of professional dermatologists contribute to the market's expansion in this region. In the American region, the presence of albinism is increasing, and the growing incidence of albinism is expected to drive the market growth of the hyperpigmentation treatment in the forecast period of 2024-2030. Thus, the increasing prevalence of pigmentation disorders, rising research and development activities, and increasing adoption of business strategies by companies are all expected to fuel market growth in the region over the forecast period.
- In January 2023, Allergan Aesthetics American company launched the SkinMedica Even & Correct Collection, designed to even skin tone and reduce the appearance of dark spots.
- In February 2024, L'Oréal Paris a global beauty brand introduced the Glycolic Bright Dark Circle Eye Serum, which targets under-eye hyperpigmentation.
Asia Pacific is expected to register the fastest growth during the forecast period of 2024-2030 due to increasing laser treatment for skin conditions, rising incidence of multiple skin disorders, increasing awareness about skin rejuvenation, and growing demand for cosmetic treatments in countries such as China, India, and Japan. Hyperpigmentation (dark spots) is caused by an excessive production of melanin in the skin. Asian skin tends to have more melanin than Caucasian skin, and as a result, Asian skin is more prone to skin discoloration. Furthermore, the presence of a large patient base and increasing disposable incomes are also expected to drive the growth of the hyperpigmentation treatment market in the Asia-Pacific region.
Hyperpigmentation Treatment Market Competitive Landscape
The key players of the Hyperpigmentation Treatment Market are the Vivier Pharma, L’Oréal Paris, La Roche-Posay, Pierre Fabre Dermo Cosmetique, Bayer, Alvogen, Allergen, SkinCeuticals International, others. La Roche-Posay is one of the leading skin treatment provider companies which help people to recover from skin-related side effects of cancer treatment. La Roche-Posey’s skin care line includes a wide range of face and body products including some condition-specific requirements. La Roche-Posay is the most dermatologist recommended brands out there due to their mild formulas and special attention to the skin conditions such as eczema, dryness and acne. The main ingredient the use in their products is their selenium-rich thermal spring water. In products they include ingredients like niacinamide, salicylic acid, a form of vitamin B3, and vegetable glycerin to moisturize the skin.
- In 2024, La Roche-Posay launched the MELA B3 range, which includes the MELA B3 Clarifying Micro-Peeling Gel Cleanser, the MELA B3 Serum, and the MELA B3 SPF 30. This range uses Melasyl (2-MNG), that targets skin pigmentation. The product is designed to intercept excess melanin before it reaches the skin's surface, showing results just in one week.
L'Oréal Paris, a prominent subsidiary of the L'Oréal Group, holds a strong position in the global beauty market. L'Oréal Paris offers a wide variety of beauty products, including skincare, haircare, makeup, and men's grooming items. L'Oréal Paris excels in marketing, leveraging celebrity endorsements and collaborations with influencers to enhance its brand image. The brand’s commitment to sustainability, with initiatives like the “Sharing Beauty With All” program, aims to reduce its environmental impact and promote ethical practices.
- In 2024, L'Oréal showcased several innovations at VivaTech-2024, including advanced skin diagnostics tools, a GenAI-powered beauty assistant, and bioprinted skin technology that mimics human skin more accurately for product testing. These advancements reflect L'Oréal's dedication to integrating cutting-edge technology to offer personalized and inclusive beauty solutions?.
Hyperpigmentation Treatment Market Scope |
|
Market Size in 2023 |
USD 2.70 Billion |
Market Size in 2030 |
USD 6.08 Billion |
CAGR (2023-2030) |
8.64 % |
Historic Data |
2018-2022 |
Base Year |
2023 |
Forecast Period |
2024-2030 |
Segments |
By Treatment Type
|
By Indication
|
|
By End User
|
Key Regions
- North America (United States, Canada, Mexico)
- Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Rest of Europe)
- Asia Pacific (China, S Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, Rest of Asia Pacific)
- Middle East and Africa (South Africa, GCC, Egypt, Nigeria, Rest of MEA)
- South America (Brazil, Mexico, Rest of South America)
Key Players
- Episciences
- Vivier Pharma
- La Roche-Posay
- Pierre Fabre Dermo Cosmetique
- Bayer
- Alvogen
- Allergen
- Obagi Medical Products
- SkinCeuticals International
- L’Oréal Paris
- Biocosmetic Research Labs
- Sedgh Plastic Surgery
- Dermatologikum Berlin
- Skin Deep Laser Services
- Medical Beauty Cologne
- Dermatology Private Clinic Dr. med. Aresu Naderi
- The Harley Street Dermatology Clinic
- Premier Laser Clinic UK Ltd.
- Qazi Cosmetic Center
- ABBY SKIN CLINIC
- The Marbella Vein & Beauty Clinic
- Aerolase
- CP Skin Health Group, Inc.
- Trophy Skin Products LLC
- The Alchemee LLC
- The Procter and Gamble Company
- Galderma S.A
- Others
Frequently Asked Questions
The global Hyperpigmentation Treatment market is expected to grow with a CAGR of 8.64% over the forecast period.
North America is the leading region of the Hyperpigmentation market with the largest share in 2023.
The market size of the Hyperpigmentation Treatment market in 2023 is USD 6.08 Billion.
1. Hyperpigmentation Treatment Market: Research Methodology
2. Hyperpigmentation Treatment Market: Competitive Landscape
2.1. Stellar Competition Matrix
2.2. Competitive Landscape
2.3. Key Players Benchmarking
2.4. Market Structure
2.4.1. Market Leaders
2.4.2. Market Followers
2.4.3. Emerging Players
2.5. Consolidation of the Market
3. Hyperpigmentation Treatment Market: Executive Summary
4. Hyperpigmentation Treatment Market: Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Market Challenges
4.5. Regulatory Landscape by Region
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Middle East and Africa
4.5.5. South America
5. Hyperpigmentation Treatment Market Size and Forecast by Segments (by Value USD Billion)
5.1. Hyperpigmentation Treatment Market Size and Forecast, by Treatment Type (2023-2030)
5.1.1. Topical Agent
5.1.2. Photo Therapy
5.1.3. Microdermabrasion
5.1.4. Pharmacological Therapy
5.1.5. Laser Treatment
5.1.6. Chemical Peels and Bleach
5.2. Hyperpigmentation Treatment Market Size and Forecast, by Indication (2023-2030)
5.2.1. Age Spot
5.2.2. Melasma
5.2.3. Post-inflammatory hyperpigmentation (PIH)
5.2.4. Other
5.3. Hyperpigmentation Treatment Market Size and Forecast, by End User (2023-2030)
5.3.1. Hospitals
5.3.2. Dermatological clinics
5.3.3. Aesthetics centre
5.3.4. Others
5.4. Hyperpigmentation Treatment Market Size and Forecast, by region (2023-2030)
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Middle East and Africa
5.4.5. South America
6. North America Hyperpigmentation Treatment Market Size and Forecast (by Value USD Billion)
6.1. North America Hyperpigmentation Treatment Market Size and Forecast, by Treatment Type (2023-2030)
6.1.1. Topical Agent
6.1.2. Photo Therapy
6.1.3. Microdermabrasion
6.1.4. Pharmacological Therapy
6.1.5. Laser Treatment
6.1.6. Chemical Peels and Bleach
6.2. North America Hyperpigmentation Treatment Market Size and Forecast, by Indication (2023-2030)
6.2.1. Age Spot
6.2.2. Melasma
6.2.3. Post-inflammatory hyperpigmentation (PIH)
6.2.4. Other
6.3. North America Hyperpigmentation Treatment Market Size and Forecast, by End User (2023-2030)
6.3.1. Hospitals
6.3.2. Dermatological clinics
6.3.3. Aesthetics centre
6.3.4. Others
6.4. North America Hyperpigmentation Treatment Market Size and Forecast, by Country (2023-2030)
6.4.1. United States
6.4.2. Canada
6.4.3. Mexico
7. Europe Hyperpigmentation Treatment Market Size and Forecast (by Value USD Billion)
7.1. Europe Hyperpigmentation Treatment Market Size and Forecast, by Treatment Type (2023-2030)
7.1.1. Topical Agent
7.1.2. Photo Therapy
7.1.3. Microdermabrasion
7.1.4. Pharmacological Therapy
7.1.5. Laser Treatment
7.1.6. Chemical Peels and Bleach
7.2. Europe Hyperpigmentation Treatment Market Size and Forecast, by Indication (2023-2030)
7.2.1. Age Spot
7.2.2. Melasma
7.2.3. Post-inflammatory hyperpigmentation (PIH)
7.2.4. Other
7.3. Europe Hyperpigmentation Treatment Market Size and Forecast, by End User (2023-2030)
7.3.1. Hospitals
7.3.2. Dermatological clinics
7.3.3. Aesthetics centre
7.3.4. Others
7.4. Europe Hyperpigmentation Treatment Market Size and Forecast, by Country (2023-2030)
7.4.1. UK
7.4.2. France
7.4.3. Germany
7.4.4. Italy
7.4.5. Spain
7.4.6. Sweden
7.4.7. Austria
7.4.8. Rest of Europe
8. Asia Pacific Hyperpigmentation Treatment Market Size and Forecast (by Value USD Billion)
8.1. Asia Pacific Hyperpigmentation Treatment Market Size and Forecast, by Treatment Type (2023-2030)
8.1.1. Topical Agent
8.1.2. Photo Therapy
8.1.3. Microdermabrasion
8.1.4. Pharmacological Therapy
8.1.5. Laser Treatment
8.1.6. Chemical Peels and Bleach
8.2. Asia Pacific Hyperpigmentation Treatment Market Size and Forecast, by Indication (2023-2030)
8.2.1. Age Spot
8.2.2. Melasma
8.2.3. Post-inflammatory hyperpigmentation (PIH)
8.2.4. Other
8.3. Asia Pacific Hyperpigmentation Treatment Market Size and Forecast, by End User (2023-2030)
8.3.1. Hospitals
8.3.2. Dermatological clinics
8.3.3. Aesthetics centre
8.3.4. Others
8.4. Asia Pacific Hyperpigmentation Treatment Market Size and Forecast, by Country (2023-2030)
8.4.1. China
8.4.2. S Korea
8.4.3. Japan
8.4.4. India
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Malaysia
8.4.8. Vietnam
8.4.9. Taiwan
8.4.10. Bangladesh
8.4.11. Pakistan
8.4.12. Rest of Asia Pacific
9. Middle East and Africa Hyperpigmentation Treatment Market Size and Forecast (by Value USD Billion)
9.1. Middle East and Africa Hyperpigmentation Treatment Market Size and Forecast, by Treatment Type (2023-2030)
9.1.1. Topical Agent
9.1.2. Photo Therapy
9.1.3. Microdermabrasion
9.1.4. Pharmacological Therapy
9.1.5. Laser Treatment
9.1.6. Chemical Peels and Bleach
9.2. Middle East and Africa Hyperpigmentation Treatment Market Size and Forecast, by Indication (2023-2030)
9.2.1. Age Spot
9.2.2. Melasma
9.2.3. Post-inflammatory hyperpigmentation (PIH)
9.2.4. Other
9.3. Middle East and Africa Hyperpigmentation Treatment Market Size and Forecast, by End User (2023-2030)
9.3.1. Hospitals
9.3.2. Dermatological clinics
9.3.3. Aesthetics centre
9.3.4. Others
9.4. Middle East and Africa Hyperpigmentation Treatment Market Size and Forecast, by Country (2023-2030)
9.4.1. South Africa
9.4.2. GCC
9.4.3. Egypt
9.4.4. Nigeria
9.4.5. Rest of MEA
10. South America Hyperpigmentation Treatment Market Size and Forecast (by Value USD Billion)
10.1. South America Hyperpigmentation Treatment Market Size and Forecast, by Treatment Type (2023-2030)
10.1.1. Topical Agent
10.1.2. Photo Therapy
10.1.3. Microdermabrasion
10.1.4. Pharmacological Therapy
10.1.5. Laser Treatment
10.1.6. Chemical Peels and Bleach
10.2. South America Hyperpigmentation Treatment Market Size and Forecast, by Indication (2023-2030)
10.2.1. Age Spot
10.2.2. Melasma
10.2.3. Post-inflammatory hyperpigmentation (PIH)
10.2.4. Other
10.3. South America Hyperpigmentation Treatment Market Size and Forecast, by End User (2023-2030)
10.3.1. Hospitals
10.3.2. Dermatological clinics
10.3.3. Aesthetics centre
10.3.4. Others
10.4. South America Hyperpigmentation Treatment Market Size and Forecast, by Country (2023-2030)
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Rest of South America
11. Company Profile: Key players
11.1. La Roche-Posay
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Business Portfolio
11.1.4. SWOT Analysis
11.1.5. Business Strategy
11.1.6. Recent Developments
11.2. Episciences
11.3. Vivier Pharma
11.4. Pierre Fabre Dermo Cosmetique
11.5. Bayer
11.6. Alvogen
11.7. Allergen
11.8. Obagi Medical Products
11.9. SkinCeuticals International
11.10. L’Oréal Paris
11.11. Biocosmetic Research Labs
11.12. Sedgh Plastic Surgery
11.13. Dermatologikum Berlin
11.14. Skin Deep Laser Services
11.15. Medical Beauty Cologne
11.16. Dermatology Private Clinic Dr. med. Aresu Naderi
11.17. The Harley Street Dermatology Clinic
11.18. Premier Laser Clinic UK Ltd.
11.19. Qazi Cosmetic Center
11.20. ABBY SKIN CLINIC
11.21. The Marbella Vein & Beauty Clinic
11.22. Aerolase
11.23. CP Skin Health Group, Inc.
11.24. Trophy Skin Products LLC
11.25. The Alchemee LLC
11.26. The Procter and Gamble Company
11.27. Galderma S.A
12. Key Findings
13. Industry Recommendations